Issue Date | Title | Author(s) | Source | scopus | WOS | Fulltext/Archive link |
2016 | MED12 exon 2 mutation as a highly sensitive and specific marker in distinguishing phyllodes tumours from other spindle neoplasms of the breast | HUANG-CHUN LIEN ; CHIUN-SHENG HUANG ; YA-WEN YANG ; YUNG-MING JENG | APMIS | 11 | 8 | |
2018 | Metabolic risk factors are associated with non-hepatitis B non-hepatitis C hepatocellular carcinoma in Taiwan, an endemic area of chronic hepatitis B | Huang, Shiu-Feng; Chang, Il-Chi; Hong, Chih-Chen; Yen, Tseng-Chang; CHI-LING CHEN ; Wu, Cheng-Chung; Tsai, Cheng-Chung; MING-CHIH HO ; Lee, Wei-Chen; Yu, Hsien-Chung; Shen, Ying-Ying; Eng, Hock-Liew; Wang, John; Tseng, Hui-Hwa; YUNG-MING JENG ; Yeh, Chau-Ting; Chen, Chi-Ling; PEI-JER CHEN ; Liaw, Yun-Fan | Hepatology communications | 32 | 30 | |
2021 | Metronomic chemotherapy with tegafur-uracil following radical resection in stage II colorectal cancer | TZU-CHUN CHEN ; YUNG-MING JENG ; JIN-TUNG LIANG | Journal of the Formosan Medical Association | 4 | 2 | |
2017 | Microinsertions in PRKACA cause activation of the protein kinase A pathway in cardiac myxoma | Tseng I.-C.; Huang W.-J.; Jhuang Y.-L.; Chang Y.-Y.; Hsu H.-P.; YUNG-MING JENG | Journal of Pathology | 14 | 11 | |
2012 | MicroRNA 3' end nucleotide modification patterns and arm selection preference in liver tissues | Li S.-C.; Tsai K.-W.; Pan H.-W.; YUNG-MING JENG ; Ho M.-R.; Li W.-H. | BMC Systems Biology | 39 | 39 | |
2010 | MicroRNA-519c suppresses hypoxia-inducible factor-1α expression and tumor angiogenesis | Cha S.-T.; Chen P.-S.; Johansson G.; CHIA-YU CHU ; Wang M.-Y.; YUNG-MING JENG ; SUNG-LIANG YU ; JIN-SHING CHEN ; KING-JEN CHANG ; Jee S.-H.; CHING-TING TAN ; MING-TSAN LIN ; Kuo M.-L. | Cancer Research | 186 | 163 | |
2004 | Microvessel density, cyclo-oxygenase 2 expression, K-ras mutation and p53 overexpression in colonic cancer | JIN-TUNG LIANG ; KUO-CHIN HUANG ; YUNG-MING JENG ; PO-HUANG LEE ; HONG-SHIEE LAI ; Hsu H.-C. | British Journal of Surgery | 51 | 45 | |
2013 | MiR-520h-mediated FOXC2 regulation is critical for inhibition of lung cancer progression by resveratrol | Yu Y.-H.; Chen H.-A.; Chen P.-S.; Cheng Y.-J.; Hsu W.-H.; Chang Y.-W.; Chen Y.-H.; Jan Y.; Hsiao M.; Chang T.-Y.; Liu Y.-H.; YUNG-MING JENG ; Wu C.-H.; Huang M.-T.; Su Y.-H.; Hung M.-C.; Chien M.-H.; Chen C.-Y.; Kuo M.-L.; Su J.-L. | Oncogene | 122 | 105 | |
2019 | Mist1: a novel nuclear marker for acinic cell carcinoma of the salivary gland | MIN-SHU HSIEH ; YUNG-MING JENG ; Lee Y.-H. | Virchows Archiv | 12 | 11 | |
2015 | MLN4924, a Novel NEDD8-activating enzyme inhibitor, exhibits antitumor activity and enhances cisplatin-induced cytotoxicity in human cervical carcinoma: In vitro and in vivo study | WEI-CHOU LIN ; Kuo K.-L.; Shi C.-S.; Wu J.-T.; Hsieh J.-T.; HONG-CHIANG CHANG ; Liao S.-M.; Chou C.-T.; CHIH-KANG CHIANG ; Chiu W.-S.; Chiu T.-Y.; YEONG-SHIAU PU ; Ho I.-L.; Wang Z.-H.; Chang S.-C.; SHING-HWA LIU ; YUNG-MING JENG ; KUO-HOW HUANG | American Journal of Cancer Research | 18 | | |
2021 | Molecular features of primary hepatic undifferentiated carcinoma | JIA-HUEI TSAI ; YUNG-MING JENG ; Lee, Chia-Hsiang; JAU-YU LIAU | Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc | 3 | 3 | |
2014 | Morphological subclassification of intrahepatic cholangiocarcinoma: Etiological, clinicopathological, and molecular features | JAU-YU LIAU ; JIA-HUEI TSAI ; RAY-HWANG YUAN ; Chang C.-N.; Lee H.-J.; YUNG-MING JENG | Modern Pathology | 197 | 160 | |
2017 | A multidisciplinary team care approach improves outcomes in high-risk pediatric neuroblastoma patients | HSIU-HAO CHANG ; Liu, Yen-Lin; MENG-YAO LU ; SHIANN-TANG JOU ; YUNG-LI YANG ; Lin, Dong-Tsamn; Lin, Kai-Hsin; KAI-YUAN TZEN ; RUOH-FANG YEN ; CHING-CHU LU ; CHIA-JU LIU ; STEVEN SHINN-FORNG PENG ; YUNG-MING JENG ; Huang, Shiu-Feng; HSIN-YU LEE ; Juan, Hsueh-Fen ; MIN-CHUAN HUANG ; Liao, Yung-Feng; Lee, Ya-Ling; WEN-MING HSU | Oncotarget | 17 | 14 | |
2022 | Multimodal 3-D/2-D human islet and duct imaging in exocrine and endocrine lesion environment: associated pancreas tissue remodeling | Chung, Mei-Hsin; Chien, Hung-Jen; Peng, Shih-Jung; Chou, Ya-Hsien; Chiang, Tsai-Chen; Chang, Hsiu-Pi; CHIH-YUAN LEE ; CHIEN-CHIA CHEN ; YUNG-MING JENG ; YU-WEN TIEN ; Tang, Shiue-Cheng | American journal of physiology. Endocrinology and metabolism | 3 | 0 | |
2002 | Multiple intrahepatic biliary cysts in children with biliary atresia | Bu L.-N.; HUEY-LING CHEN ; YEN-HSUAN NI ; STEVEN SHINN-FORNG PENG ; YUNG-MING JENG ; HONG-SHIEE LAI ; MEI-HWEI CHANG | Journal of Pediatric Surgery | 45 | 27 | |
2009 | Multiple lineages of human breast cancer stem/progenitor cells identified by profiling with stem cell markers | Hwang-Verslues W.W.; WEN-HUNG KUO ; Chang P.-H.; Pan C.-C.; Wang H.-H.; Tsai S.; YUNG-MING JENG ; Shew J.-Y.; Kung J.T.; Chen C.-H.; Lee E.Y.-H.P.; KING-JEN CHANG ; Lee W.-H. | PLoS ONE | 191 | 175 | |
2011 | Mutation and loss of expression of ARID1A in uterine low-grade endometrioid carcinoma | Guan B.; TSUI-LIEN MAO ; Panuganti P.K.; Kuhn E.; Kurman R.J.; Maeda D.; Chen E.; YUNG-MING JENG ; Wang T.-L.; Shih I.-M. | American Journal of Surgical Pathology | 229 | 213 | |
2002 | Mutation of the DR5/TRAIL receptor 2 gene is infrequent in hepatocellular carcinoma | YUNG-MING JENG ; Hsu H.-C. | Cancer Letters | 26 | 23 | |
2016 | Mutational analysis of MED12 exon 2 in a spectrum of fibroepithelial tumours of the breast: Implications for pathogenesis and histogenesis | HUANG-CHUN LIEN ; CHIUN-SHENG HUANG ; YA-WEN YANG ; YUNG-MING JENG | Histopathology | 28 | 24 | |
2020 | MYCN RNA levels determined by quantitative in situ hybridization is better than MYCN gene dosages in predicting the prognosis of neuroblastoma patients | HSIU-HAO CHANG ; Tseng Y.-F.; MENG-YAO LU ; YUNG-LI YANG ; SHU-WEI CHOU ; Lin D.-T.; Lin K.-H.; SHIANN-TANG JOU ; WEN-MING HSU ; YUNG-MING JENG | Modern Pathology | 11 | 10 | |